Your browser doesn't support javascript.
loading
Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis.
van de Meeberg, Maartje M; Verheij, Elwin R; Fidder, Herma H; Bouma, Gerd; Huitema, Alwin D R; Oldenburg, Bas.
Affiliation
  • van de Meeberg MM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Verheij ER; Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AGEM Research Institute, Amsterdam.
  • Fidder HH; TNO Healthy Living, Zeist.
  • Bouma G; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Huitema ADR; Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, AGEM Research Institute, Amsterdam.
  • Oldenburg B; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht.
Ther Drug Monit ; 45(5): 668-675, 2023 10 01.
Article in En | MEDLINE | ID: mdl-36823707
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Mesalamine Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Ther Drug Monit Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Mesalamine Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Ther Drug Monit Year: 2023 Type: Article